Literature DB >> 22528332

To bridge or not to bridge: these are the questions.

Robert W Harrison1, Thomas L Ortel, Richard C Becker.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22528332     DOI: 10.1007/s11239-012-0732-8

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  22 in total

1.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.

Authors:  J D Douketis; M A Crowther; S S Cherian
Journal:  Can J Cardiol       Date:  2000-03       Impact factor: 5.223

3.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

4.  Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

Authors:  Brian F Gage; Yan Yan; Paul E Milligan; Amy D Waterman; Robert Culverhouse; Michael W Rich; Martha J Radford
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

5.  Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.

Authors:  A C Spyropoulos; A G G Turpie; A S Dunn; J Spandorfer; J Douketis; A Jacobson; F J Frost
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

6.  Guideline-discordant periprocedural interruptions in warfarin therapy.

Authors:  Lesli E Skolarus; Lewis B Morgenstern; James B Froehlich; Lynda D Lisabeth; Devin L Brown
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-02-08

7.  Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry.

Authors:  C Hammerstingl; A Schmitz; R Fimmers; H Omran
Journal:  Cardiovasc Ther       Date:  2009       Impact factor: 3.023

8.  Risk of stroke after surgery in patients with and without chronic atrial fibrillation.

Authors:  S Kaatz; J D Douketis; H Zhou; B F Gage; R H White
Journal:  J Thromb Haemost       Date:  2010-01-24       Impact factor: 5.824

9.  Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin.

Authors:  A Malato; G Saccullo; L Lo Coco; D Caramazza; I Abbene; G Pizzo; A Casuccio; S Siragusa
Journal:  J Thromb Haemost       Date:  2009-10-11       Impact factor: 5.824

10.  Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.

Authors:  M J Kovacs; C Kearon; M Rodger; D R Anderson; A G G Turpie; S M Bates; L Desjardins; J Douketis; S R Kahn; S Solymoss; P S Wells
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

View more
  2 in total

1.  Comparison of hemostatic dressings for superficial wounds using a new spectrophotometric coagulation assay.

Authors:  Julian-Dario Rembe; Julia K Böhm; Carolin Fromm-Dornieden; Nadine Schäfer; Marc Maegele; Matthias Fröhlich; Ewa K Stuermer
Journal:  J Transl Med       Date:  2015-11-30       Impact factor: 5.531

Review 2.  Current strategies to minimize the bleeding risk of warfarin.

Authors:  David Snipelisky; Fred Kusumoto
Journal:  J Blood Med       Date:  2013-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.